Ken Gall is the current director at Orthobond. Ken has over 25 years of experience in the medical device industry. Prior to their current position, Ken was the CEO of Reselute, a startup medical device company. Ken has also held leadership positions at Synergy Biomedical, Sparta Biomedical, and Orthobond Corporation. Ken has a B.S. in mechanical engineering from Duke University.
Ken Gall received their PhD in Mechanical Engineering from the University of Illinois Urbana-Champaign. Ken also holds a Master of Science in Mechanical Engineering from the same school, as well as a Bachelor of Science in Mechanical Engineering from the University of Illinois Urbana-Champaign.
This person is not in the org chart